肝细胞核因子4α通过调控p53和胆汁酸信号通路阻止小鼠脂肪变性向NASH进展
该研究在小鼠中探究肝细胞核因子4α(HNF4α)功能获得或缺失对非酒精性脂肪性肝病(NAFLD)发生和进展的影响。过表达人HNF4α可预防高脂/胆固醇/果糖(HFCF)饮食诱导的脂肪性肝炎,而缺失Hnf4α则产生相反效应;HNF4α通过促进肝脏甘油三酯脂解、脂肪酸氧化和VLDL分泌防止肝脏甘油三酯蓄积,并抑制NAFL向NASH进展。过表达人HNF4α在对照小鼠中抑制HFCF饮食诱导的脂肪性肝炎,但在肝细胞特异性p53-/-小鼠中无此作用;在缺乏肝脏Hnf4α的HFCF饮食喂养小鼠中,恢复肝脏HNF4α靶基因胆固醇7α-羟化酶和甾醇12α-羟化酶的表达可使肝脏甘油三酯水平正常化并减轻脂肪性肝炎。结论提示HNF4α通过协调调控脂解、p53和胆汁酸信号通路防止饮食诱导的NAFLD发生和进展,靶向肝脏HNF4α可能有助于治疗NASH。
要点
- 过表达人HNF4α可预防HFCF饮食诱导的小鼠脂肪性肝炎,缺失Hnf4α则产生相反效应。
- HNF4α通过促进肝脏甘油三酯脂解、脂肪酸氧化和VLDL分泌防止肝脏甘油三酯蓄积。
- HNF4α抑制NAFL向NASH进展,其作用依赖肝细胞p53及胆汁酸信号通路。
核心结论
- HNF4α通过协调调控脂解、p53和胆汁酸信号通路防止饮食诱导的NAFLD发生和进展。
- 靶向肝脏HNF4α可能有助于治疗NASH。
研究设计与样本
- 在小鼠中研究HNF4α功能获得或缺失对NAFLD发生和进展的影响。
- 使用高脂/胆固醇/果糖(HFCF)饮食诱导的脂肪性肝炎模型。
- 使用肝细胞特异性p53-/-小鼠。
- 使用缺乏肝脏Hnf4α的HFCF饮食喂养小鼠。
主要发现
- 过表达人HNF4α可预防HFCF饮食诱导的脂肪性肝炎,而缺失Hnf4α则产生相反效应。
- HNF4α通过促进肝脏甘油三酯脂解、脂肪酸氧化和VLDL分泌防止肝脏甘油三酯蓄积。
- 过表达人HNF4α在对照小鼠中抑制HFCF饮食诱导的脂肪性肝炎,但在肝细胞特异性p53-/-小鼠中无此作用。
- 在缺乏肝脏Hnf4α的HFCF饮食喂养小鼠中,恢复肝脏HNF4α靶基因胆固醇7α-羟化酶和甾醇12α-羟化酶的表达可使肝脏甘油三酯水平正常化并减轻脂肪性肝炎。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Hepatocyte nuclear factor 4α (HNF4α) is highly enriched in the liver, but its role in the progression of nonalcoholic liver steatosis (NAFL) to NASH has not been elucidated. In this study, we investigated the effect of gain or loss of HNF4α function on the development and progression of NAFLD in mice. APPROACH AND RESULTS: Overexpression of human HNF4α protected against high-fat/cholesterol/fructose (HFCF) diet-induced steatohepatitis, whereas loss of Hnf4α had opposite effects. HNF4α prevented hepatic triglyceride accumulation by promoting hepatic triglyceride lipolysis, fatty acid oxidation, and VLDL secretion. Furthermore, HNF4α suppressed the progression of NAFL to NASH. Overexpression of human HNF4α inhibited HFCF diet-induced steatohepatitis in control mice but not in hepatocyte-specific p53-/- mice. In HFCF diet-fed mice lacking hepatic Hnf4α, recapitulation of hepatic expression of HNF4α targets cholesterol 7α-hydroxylase and sterol 12α-hydroxylase and normalized hepatic triglyceride levels and attenuated steatohepatitis. CONCLUSIONS: The current study indicates that HNF4α protects against diet-induced development and progression of NAFLD by coordinating the regulation of lipolytic, p53, and bile acid signaling pathways. Targeting hepatic HNF4α may be useful for treatment of NASH.
引用
- Xu Y, Zhu Y, Hu S, et al. Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice). Hepatology. 2021. PMID: 33098092. doi:10.1002/hep.31604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。